To inhibit Centaurin α2, several chemicals can be utilized. Wortmannin, a fungal metabolite, irreversibly inhibits phosphatidylinositol 3-kinase (PI3K) by covalently modifying its ATP-binding site. This prevents the activation of PI3K and disrupts the downstream signaling pathway involving PtdInsP3, thereby inhibiting the activation of Centaurin α2. Similarly, LY 294002, a synthetic compound, competitively inhibits PI3K by binding to its catalytic site, interfering with its activation and subsequent signaling pathway. Another approach to inhibiting Centaurin α2 is by targeting the upstream or downstream components of its signaling pathways. U-73122, a selective inhibitor of phospholipase C (PLC), reduces the production of InsP4 by inhibiting the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2). Since Centaurin α2 binds to InsP4, the inhibition of PLC indirectly inhibits the binding of Centaurin α2 to InsP4.
NSC 23766 Trihydrochloride targets Rho GTPases, downstream effectors of Centaurin α2. By inhibiting Rho GTPases, this compound disrupts the downstream signaling pathway involving Rho GTPases, indirectly affecting the activation of Centaurin α2. Arfaptin-1 and Brefeldin A inhibit the activation of Arfs, which are upstream regulators of Centaurin α2. Arfaptin-1 is a synthetic peptide that specifically inhibits Arfs, while Brefeldin A disrupts the integrity of the Golgi apparatus, leading to the inhibition of Arf activation. Other inhibitors include Y-27632, free base, which selectively inhibits ROCKs (downstream effectors of Rho GTPases), PIK-75, hydrochloride, a selective inhibitor of PI3K, and U0126, a selective inhibitor of MEK1/2 in the MAPK signaling pathway. These inhibitors disrupt the respective signaling pathways, indirectly affecting the activation of Centaurin α2. In summary, Centaurin α2 inhibitors target various components of its signaling pathways, including PI3K, PLC, Rho GTPases, Arfs, ROCKs, and MAPK signaling. These inhibitors interfere with the activation and downstream signaling of Centaurin α2, providing potential strategies for modulating its function in cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Fungal metabolite that irreversibly inhibits phosphatidylinositol 3-kinase (PI3K) by covalently modifying its ATP site. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Synthetic compound that competitively inhibits PI3K by binding to its catalytic site. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Fungal metabolite that inhibits the activation of Arfs by disrupting the integrity of the Golgi apparatus. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Selective inhibitor of Rho-associated protein kinases (ROCKs), downstream effectors of Rho GTPases. | ||||||
PIK-75, hydrochloride | 372196-77-5 | sc-296089 sc-296089A | 1 mg 5 mg | $29.00 $124.00 | ||
Selective inhibitor of PI3K, specifically targeting the p110α isoform. | ||||||
AS-252424 | 900515-16-4 | sc-202961 sc-202961A | 1 mg 5 mg | $42.00 $158.00 | ||
Small molecule inhibitor that specifically targets the Rho family of GTPases. | ||||||